Latest Health News
Seven Million Cancers Preventable Worldwide
Up to four in ten cancer cases globally, or 7.1 million in 2022, could be prevented through addressing 30 modifiable risk factors like tobacco and air pollution, per WHO and IARC report. Air pollution drives many cases.
Progress in cancer prevention discussed at World Economic Forum 2026.
Measles Outbreak Hits South Carolina
South Carolina reports 920 measles cases, mainly in Greenville and Spartanburg, due to low vaccination rates, expected to last weeks or months. Most cases in unvaccinated individuals, boosting state vaccinations in January.
Fatal Nipah Virus Case in Bangladesh
A deadly Nipah virus case reported in northern Bangladesh follows two in India, prompting Asian airport screenings. Linked to bat-contaminated food, it's highly fatal but low person-to-person spread risk per WHO.
Francesco Muntoni Wins 2026 Novo Nordisk Prize for DMD RNA Therapies
Professor Francesco Muntoni awarded for pioneering RNA-based exon-skipping therapies restoring dystrophin in Duchenne muscular dystrophy (DMD), leading to first approved treatments in 2016-2019. His work shifted DMD from inevitable to treatable via genetic intervention.
Focus now on next-gen RNA and neurological aspects.
World Obesity Day 2026 Raises Alarm on Global Epidemic
Observed March 4, theme 'Together, we can change the story of obesity' addresses stigma, food systems, care access, recognizing it as chronic disease. By 2035, ~4 billion may be obese/overweight; rising childhood rates in low/middle-income countries.
Early intervention prevents diabetes, heart disease.
Mount Sinai and King Saud University Partner on IBD Precision Medicine
Three-year collaboration studies familial inflammatory bowel disease (IBD) using multi-omics for early risk signals and personalized treatments. Combines KSUMC's family cohorts with Mount Sinai's biomarker expertise for global impact.
Aims to enable prevention amid rising IBD worldwide.
Breast Cancer: 2.3 Million New Cases in 2023
Lancet Oncology reports 2.3 million new breast cancer cases and 764,000 deaths in 2023, causing 24 million healthy life years lost. Remains most common cancer globally.
SHERPA Consortium Launches AI Studies for Brain and Cancer Treatments
Initiates seven clinical studies validating AI assistive tech for minimally invasive procedures at top European hospitals. Addresses physician shortages projected at 600k in EU by 2030.
Featured at ECR 2026 on March 4.
J&J's Nipocalimab Gets FDA Fast Track for Lupus
Nipocalimab, an FcRn blocker, granted Fast Track for systemic lupus erythematosus (SLE) after Phase 2b success reducing disease activity. Affects 3-5 million worldwide; Phase 3 underway.
Offers hope for targeted therapy.
Antengene and UCB License ATG-201 for Autoimmune Diseases
Global deal for CD19/CD3 bispecific T-cell engager ATG-201, designed for safe B-cell depletion with low CRS risk via masking tech. Antengene to run initial Phase 1 in China/Australia; UCB takes over.
Targets immunology diseases.
FGM Prevalence Drops but Risks Reversal
Proportion of girls subjected to female genital mutilation fell from 1 in 2 to 1 in 3 via education and campaigns, but needs sustained funding. UN warns of reversal without commitment.
New NIH Grant Funds Lupus Protein Research
$1.7 million NIH grant to OU researcher advances study of protein aiding lupus understanding and treatment.